Current Cancer Drug Targets


Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204

Personal Subscription
Become EABM
Become Reviewer

Editorial [ Apoptotic Pathways as Targets for Therapeutic Intervention Guest Editor: Domagoj Vucic ] promotion: free to download

Volume:8   Issue: 2
Pp: 86-86
Domagoj Vucic
DOI: 10.2174/156800908783769364

p53: A Guide to Apoptosis

Volume:8   Issue: 2
Pp: 87-97
Erik Meulmeester and Aart G. Jochemsen
DOI: 10.2174/156800908783769337

Targeting Cell Death in Tumors by Activating Caspases

Volume:8   Issue: 2
Pp: 98-109
A. Clay Clark and Sarah H. MacKenzie
DOI: 10.2174/156800908783769391

Ubiquitylation and Cancer Development

Volume:8   Issue: 2
Pp: 118-123
John Silke, Maria Miasari and Hamsa Puthalakath
DOI: 10.2174/156800908783769300

Tumor Necrosis Factor: Renaissance as a Cancer Therapeutic?

Volume:8   Issue: 2
Pp: 124-131
D. Daniel and N. S. Wilson
DOI: 10.2174/156800908783769346

Application of Proteome Analysis to the Assessment of Prognosis and Response Prediction in Clinical Oncology

Volume:8   Issue: 2
Pp: 141-145
Christoph Rocken, Ralf Ketterlinus and Matthias P.A. Ebert
DOI: 10.2174/156800908783769328

Natural and Synthetic Agents Targeting Inflammation and Angiogenesis for Chemoprevention of Prostate Cancer

Volume:8   Issue: 2
Pp: 146-155
Spiridione Garbisa, Elena M.V. Araldi, Isabella Dell'Aica, Ilaria Sogno, Girieca Lorusso and Adriana Albini
DOI: 10.2174/156800908783769382